Medical intervention in adolescent menorrhagia

In: Annals of King Edward Medical University · 2016 · vol. 11(4) · doi:10.21649/akemu.v11i4.1112 · W2465984520
Observational OA: diamond CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-12 ⓘ

This cross-sectional study of adolescent menorrhagia found that dysfunctional uterine bleeding was the primary cause and that NSAIDs and antifibrinolytic agents were more effective than combined oral contraceptives for reducing menstrual loss.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-28 · read from full text ⓘ

This cross-sectional study evaluated the causes of menorrhagia and the efficacy of medical interventions in fifty unmarried adolescent patients aged 12 to 19 years at Lady Willingdon Hospital. The researchers identified dysfunctional uterine bleeding as the predominant etiology, accounting for 92% of cases, while also noting contributions from bleeding disorders and endocrine abnormalities. Treatment outcomes demonstrated that non-steroidal anti-inflammatory drugs and antifibrinolytic agents achieved a 75% rate of subjective improvement, outperforming combined oral contraceptives which yielded only 66% improvement. Consequently, the authors concluded that NSAIDs and antifibrinolytics are effective first-line treatments for reducing menstrual blood loss in this demographic. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Objectives: To find out causative factors of adolescent menorrhagia and success of various treatments. Design: Descriptive cross sectional study Place & duration of study: Lady Willingdon Hospital, Lahore from May 2004 to April 2005. Subject and methods: Fifty unmarried patients at 12-19 years with menorrhagia selected by non-probability convenience sampling. Blood loss was determined by duration of bleeding extending beyond seven days, passage of clots and presence of anaemia. Results: The most common cause of menorrhagia was DUB (92%) followed by bleeding and endocrinal disorder. Non-steroidal anti-inflammatory drug and antifibrinolytic agent produced 75% subjective improvement in complaints. However, combined oral contraceptive produced 66% improvement. Conclusion: NSAIDS and antifibrinolytic drugs were found to be effective in reducing menstrual loss and should be used as first line of treatment.
Full text 1,574 characters · extracted from oa-doi-fallback · click to expand
Medical intervention in adolescent menorrhagia DOI: https://doi.org/10.21649/akemu.v11i4.1112Keywords: Menorrhagia. Cross-Sectional Study. Hospital. Achievement. Social Environment. Uterine Diseases. Cohort Studies. Hysteroscopy. Blood Coagulation Disorders. Retrospective Studies.Abstract Objectives: To find out causative factors of adolescent menorrhagia and success of various treatments. Design: Descriptive cross sectional study Place & duration of study: Lady Willingdon Hospital, Lahore from May 2004 to April 2005. Subject and methods: Fifty unmarried patients at 12-19 years with menorrhagia selected by non-probability convenience sampling. Blood loss was determined by duration of bleeding extending beyond seven days, passage of clots and presence of anaemia. Results: The most common cause of menorrhagia was DUB (92%) followed by bleeding and endocrinal disorder. Non-steroidal anti-inflammatory drug and antifibrinolytic agent produced 75% subjective improvement in complaints. However, combined oral contraceptive produced 66% improvement. Conclusion: NSAIDS and antifibrinolytic drugs were found to be effective in reducing menstrual loss and should be used as first line of treatment. Downloads Published How to Cite Issue Section License This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments [email protected]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK